Labcorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
If you have a Labcorp Oncology account, complete the test requisition form
If you do NOT have a Labcorp Oncology account, contact us for account setup
From a single tumor biopsy, analyzed by advanced next generation sequencing (NGS) technology, OmniSeq INSIGHT identifies treatment options in one comprehensive, easy-to-read report.
A single tissue sample provides complete insight into the tumor and its microenvironment.
The report provides comprehensive genomic and immune profiling for all solid tumors.
A summary of FDA-approved therapies, immunotherapies and eligible clinical trials tailored to your patient’s solid tumor.
List of patient-eligible clinical trials within 200 miles of patient’s physical address1
Comprehensive Quick-Read Results
Clinical Trial Options
Clinically significant variants with reference to details pages
Sections always show, even if results are null
VUS in appendix
Clear description of pertinent negative genomic variants
Therapy considerations summary
Flagged potential cancer-associated hereditary variants
Easy to find marker list located on last page of the report
Clear explanations of testing issues, if any
Explanation of clinical significance
Treatment settings and approval status
Number of trial matches per marker
1. OmniSeq Bioinformatics Knowledgebase - data curation January 2021.